Stem Cells Studied to Prevent Heart Dysfunction in Children With Cancer

A patient’s own stem cells will allow doctors to evaluate the risks involved in chemotherapy.

A team from the Royal Children’s Hospital, the Murdoch Children’s Research Institute and the University of Melbourne has begun studying stem cell-derived heart cells from children with cancer to observe which samples are most damaged from chemotherapy drugs.  In a first of-its-kind study, researchers are taking stem cells from the patient, growing heart cells in the lab and subjecting them to a cocktail of chemotherapy drugs. The reaction of the cells to the treatments helps determine which patients are more likely to develop heart disease [later on in life] from different chemotherapy options.

The chemotherapy drugs needed to save young cancer patients can make them 15 times more likely to develop cardiac conditions later in life.  This novel use of the patient’s own stem cells could prevent such debilitation by alerting doctors of a child’s susceptibility early on, improving the efficacy of cancer treatments.

The research is an example of how scientists are gaining insights that will facilitate more effective treatments leading to better outcomes.  To learn more about the value of preserving your own stem cells for use in future therapies and how to bank your own stem cells through a non-evasive and affordable method by recovering your dental pulp stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.

To view the full article, click here.

The Future of Regenerative Medicine is Now™.